Add BrightSurf on Google Email

Columbia University Irving Medical Center


Columbia dental school receives grant to expand oral health services for underserved children

Columbia University Irving Medical Center has received a grant from the Robert Wood Johnson Foundation to expand its oral health services for underserved children. The program, led by the School of Dental and Oral Surgery (SDOS), aims to provide comprehensive medical care, including dental services, to children in need. With the suppor...

Improving accuracy of cross-cultural neuropsychological testing

Researchers found that African Americans scored lower on neuropsychological tests due to poor educational experiences, but incorporating reading tests addressed this issue. The study suggests that including reading assessments can improve diagnosis accuracy among individuals with diverse educational backgrounds.

SourceColumbia University Irving Medical Center·JournalJournal of the International Neuropsychological Society·DateMay 20, 2002

Elderly colon cancer patients benefit from chemotherapy and surgery

Researchers found that elderly patients with lymph node involvement in colon cancer experienced a 30% reduction in mortality at five years after diagnosis with both chemotherapy and surgery. This contradicts the common assumption that age is a deterrent for these treatments, allowing doctors and patients to make more informed decisions.

SourceColumbia University Irving Medical Center·JournalAnnals of Internal Medicine·DateMay 20, 2002

2001 Louisa Gross Horwitz prize awarded to ubiquitin system researchers Avram Hershko and Alexander Varshavsky

The Louisa Gross Horwitz Prize recognizes the groundbreaking work of Dr. Avram Hershko and Dr. Alexander Varshavsky on the ubiquitin system, which regulates protein balance in cells. Their research has far-reaching implications for understanding cellular processes and diseases like cancer and neurodegenerative disorders.

Warfarin and aspirin provide no significant difference in preventing another stroke in the ischemic stroke patients

A recent study published in the New England Journal of Medicine found that warfarin and aspirin provide no significant difference in preventing another stroke in ischemic stroke patients without atrial fibrillation. The study, which followed 2,206 individuals for two years, showed no statistically significant differences between the tw...

SourceColumbia University Irving Medical Center·JournalNew England Journal of Medicine·DateNov 15, 2001

Landmark clinical trial at 22 medical centers finds implanted heart pumps lengthen and improve lives of terminally ill heart failure patients

A landmark clinical trial at 22 medical centers has found that implanted heart pumps with wearable controls significantly increase the likelihood of terminally ill heart failure patients surviving a year, with a 52.1% one-year survival rate compared to 24.7% for those receiving medication and medical monitoring.

SourceColumbia University Irving Medical Center·JournalNew England Journal of Medicine·DateNov 15, 2001

Columbia Presbyterian researchers show prostate cancer drug significantly arrests tumor growth with minimal side effects

Exisulind, a new selective apoptotic anti-neoplastic drug, delays disease progression in men with recurrent prostate cancer by slowing the rise of PSA levels. The study also found significant inhibition of tumor growth in mice, suggesting potential as a treatment option for advanced prostate cancer.

SourceColumbia University Irving Medical Center·JournalThe Journal of Urology·DateSep 28, 2001

Two genes are better than one: Combination approach selectively kills pancreatic cancer cells

Researchers at Columbia University Irving Medical Center have discovered a combination of two genes that selectively kill pancreatic cancer cells in test tube experiments. The mda-7 protein and K-ras antisense DNA combination prevents tumor growth in animals, offering a potential new treatment option for this aggressive disease.

SourceColumbia University Irving Medical Center·JournalProceedings of the National Academy of Sciences·DateSep 28, 2001

Medical news tips

Researchers at Columbia University Irving Medical Center found that levels of two blood factors associated with heart disease risk vary during a woman's menstrual cycle. Levels of PAI-1 decreased steadily as the cycle progressed, while vWF peaked at days 2 and 23, potentially increasing heart attack risk for postmenopausal women.